Skip to content

Effect of pharmacy-led medication reconciliation in the elderly patients

Effect of pharmacy-led medication reconciliation in the elderly patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005994
Enrollment
140
Registered
2021-03-12
Start date
2020-07-21
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Pharmacist service) : 1) Interview within 24 hours after admission (Comprehensive documentation of medication history, assessment of patient&#39
s usual medication status: MMAS-4 (Morisky medication adherence scale 4 item): Medication compliance, MAI (Medication Appropriateness Index): Assessment of prescription adequacy through overall medica
s prescription intervention activity at discharge: Reduction of regimen complexity (simplification of usage, matching of medication time)

Sponsors

Inha University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Hospitalized in the Department of hospital Medicine (including those who come from the intensive care unit) Senior patients 65 years of age or older who are receiving five or more drug therapy (polypharmacy) for a comorbid disease • Those who agree to participate in the research among elderly patients 65 years of age or older who were admitted to the Department of hospital Medicine at Inha University Hospital from August 2020 to February 2021 • Patients with self-communication during hospitalization or good communication with a care giver • Those who can communicate over the phone for more than 30 days after discharge or those who can communicate with a care giver

Exclusion criteria

Exclusion criteria: • Those who do not agree to participate in the research • Those whose life expectancy is less than 3 months • Patients discharged within 24 hours

Design outcomes

Primary

MeasureTime frame
The difference of adverse events reported in the control and intervention groups

Secondary

MeasureTime frame
Intervention index score change after hospitalization period, readmission, discharge, 30 days after discharge (reduction in number of MRCI-K, MAI, MMAS-4, PIMS), decrease in polypharmacy, change in the expression of adverse drug reactions

Countries

Korea, Republic of

Contacts

Public ContactSunmin LEE

Inha University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 10, 2026